financetom
Business
financetom
/
Business
/
Apple to let music streaming apps in Europe link to own websites for purchases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apple to let music streaming apps in Europe link to own websites for purchases
Apr 5, 2024 3:38 PM

By Granth Vanaik

April 5 (Reuters) - Apple ( AAPL ) announced measures on

Friday to make it easier for music streaming apps on its App

Store in the European Economic Area to inform users of other

ways to purchase digital services, as it looks to comply with a

European Union mandate.

The announcement comes weeks after the iPhone maker was

fined 1.84 billion euros ($1.99 billion) by the EU for thwarting

competition from music streaming rivals via restrictions on its

App Store.

The European Commission had said in March that Apple's ( AAPL )

restrictions constituted unfair trading conditions and that it

should stop such conduct.

Following a 2019 complaint by Swedish streaming service

Spotify ( SPOT ), the Commission charged Apple ( AAPL ) last year with

preventing the Swedish company and others from informing users

of payment options outside its App Store.

Apple ( AAPL ) on Friday said it would permit music streaming app

developers to invite users to provide their email address for

sending them a link to the developer's website to purchase

digital music content or services, and to inform them about

where and how to purchase items as well as the price.

The company said that the announcement provides "even more"

flexibility to music streaming service apps, including Spotify ( SPOT ),

which has 56% share of the European market.

Spotify ( SPOT ) did not immediately respond to a request for

comment.

Apple ( AAPL ), however, said the Commission's decision does not

address its ability to charge a commission for all the tools,

technologies and ongoing services it provides.

($1 = 0.9230 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Honda Motor Nears Deal for Canadian EV Production Facilities, Batteries, Bloomberg Reports
Market Chatter: Honda Motor Nears Deal for Canadian EV Production Facilities, Batteries, Bloomberg Reports
Apr 22, 2024
02:02 PM EDT, 04/22/2024 (MT Newswires) -- Honda Motor Company ( HMC ) is near a deal with the Canadian government to build electric vehicles and batteries in Ontario, Bloomberg News reported, citing people familiar with the matter. The news service said Canada will subsidize a portion of the capital costs for new facilities to process cathode active materials, build...
Update: Market Chatter: Jana Urges Wolfspeed to Explore Sale, Other Options
Update: Market Chatter: Jana Urges Wolfspeed to Explore Sale, Other Options
Apr 22, 2024
02:16 PM EDT, 04/22/2024 (MT Newswires) -- (Updates with additional information.) Activist investor Jana Partners urged Wolfspeed ( WOLF ) to explore ways to improve shareholder value, including a potential sale, Reuters reported Monday citing a letter it reviewed. The letter reportedly said that Goldman Sachs had assigned a $126 per share M&A price target to the company. Jana Partners...
Cherry Hill Mortgage Investment to Explore Strategic Options
Cherry Hill Mortgage Investment to Explore Strategic Options
Apr 22, 2024
02:23 PM EDT, 04/22/2024 (MT Newswires) -- Cherry Hill Mortgage Investment ( CHMI ) said Monday its board has formed a special committee to explore strategic options, including a merger or sale, to maximize shareholder value. There can be no assurance that this will lead to any transaction, the company said. Shares of the company were up nearly 7% in...
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
Apr 22, 2024
Friday, Hepion Pharmaceuticals Inc. ( HEPA ) said it has begun winding down activities in its ASCEND-NASH Trial while continuing to explore strategic alternatives, as announced in December 2023. ASCEND-NASH is a Phase 2b, randomized, multicenter, double-blinded study with the first patient screened in August 2022 to evaluate the safety and efficacy of rencofilstat dosed for 12 months, with a target enrollment of 336...
Copyright 2023-2026 - www.financetom.com All Rights Reserved